转化生长因子β激活激酶1信号通路关键调节心肌存活和重塑
Lei Li1, Yi Chen1, Jessica Doan1
1From the Department of Physiology and Biophysics, University of Washington, Seattle, WA (L.L., Y.C., J.D., J.M., Q.L.); and Howard Hughes Medical Institute, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH (J.D.M.).
Circulation
|October 4, 2014
概括
转化生长因子β激活激酶1 (TAK1) 对于心脏健康至关重要. 它的缺失会触发被编程的亡 (necroptosis),导致心力衰竭和小鼠的不良重塑.
科学领域:
- 心血管生物学 心血管生物学
- 细胞死亡机制 细胞死亡机制
- 分子信号传输的方法
背景情况:
- 计划性亡 (necroptosis) 在发育和疾病中至关重要,但其心脏调节尚不清楚.
- 死体亡在肌肉心脏重塑和心力衰竭中的作用需要进一步研究.
研究的目的:
- 研究转化生长因子β激活激酶1 (TAK1) 在调节心脏亡中的作用.
- 阐明TAK1影响心肌重塑和心力衰竭的分子机制.
主要方法:
- 在小鼠中,MAP3k7 (编码TAK1) 的心脏特异性基因切除.
- 肌细胞亡和亡的分析.
- 评估心肌重塑和心力衰竭标志物的评估.
- 对瘤亡因子受体-1 (TNFR1) 信号通路的研究.
主要成果:
- 心脏特异性的Map3k7除诱导了自发性亡和亡,导致不良的重塑和心力衰竭.
- 这些效应取决于TNFR1信号传递.
- 在TNFR1信号传递中,TAK1充当分子开关,调节涉及RIP1,FADD和酶8的细胞死亡复合物的形成.
- 在TAK1缺乏的小鼠中,抑制RIP1或RIP3改善了死细胞死亡和心力衰竭.
结论:
- 在心脏中,TAK1是关键的生存因子,直接抑制亡.
- TAK1对于维持心肌平衡和防止不良改造至关重要.
- 针对TAK1-介导的亡途径可能为心力衰竭提供治疗策略.
相关概念视频
TGF - β Signaling Pathway
7.1K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.1K
MAPK Signaling Cascades
7.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
PI3K/mTOR/AKT Signaling Pathway
5.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.1K
Interactions Between Signaling Pathways
4.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K


